首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
1-OSSO-1H-TIAZOLO[3,2-A]PIRIMIDINA2-CARBOSSAMIDI ANTIALLERGICHE E ANTIULCERA E INTERMEDI PER ESSE
摘要
申请公布号
IT8026176(D0)
申请公布日期
1980.11.21
申请号
IT19800026176
申请日期
1980.11.21
申请人
PFIZER INC.
发明人
SAUL BERNARD KADIN
分类号
A61K31/41;A61K31/425;A61K31/505;A61K31/519;A61P1/04;A61P7/10;A61P11/00;A61P17/00;A61P27/16;A61P29/00;A61P35/00;A61P37/08;A61P43/00;C07D277/40;C07D277/42;C07D277/60;C07D277/82;C07D513/04;(IPC1-7):A61K/
主分类号
A61K31/41
代理机构
代理人
主权项
地址
您可能感兴趣的专利
COSMETIC COMPOSITION COMPRISING CAMEL MILK OR COMPONENTS THEREOF
SORBENT-BASED GAS STORAGE AND DELIVERY SYSTEM FOR DISPENSING HIGH-PURITY GAS
PROCESS FOR DETECTING A MISFIRE IN AN INTERNAL COMBUSTION ENGINE AND SYSTEM FOR CARRYING OUT SAID PROCESS
COMPOSITIONS AND METHODS FOR SYSTEMIC DELIVERY OF ORAL VACCINES AND THERAPEUTIC AGENTS
5-PHENYLPYRIMIDINE, METHODS AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF AND USE OF THE SAME FOR CONTROLLING PATHOGENIC FUNGI
IMPROVED ABRASIVES FOR CHEMICAL-MECHANICAL POLISHING APPLICATIONS
COMPOUNDS CO-INDUCING CHOLINERGIC UP-REGULATION AND INFLAMMATION DOWN-REGULATION AND USES THEREOF
SOLAR ENERGY PLANT
DISTANCE WARNING SYSTEM TO PREVENT LOSS OR THEFT OF GOODS, ANIMALS AND HUMANS
PROCESS FOR NON-LINEARLY AMPLIFYING A NUCLEIC ACID SEQUENCE
POST-TERMINATION LABELING PROCESS FOR NUCLEIC ACID SEQUENCING
POLYNUCLEOTIDE CAPABLE OF HYBRIDIZING TO A COMPLEMENT OF A GENOMIC SEQUENCE OF HEPATITIS C VIRUS, POLYNUCLEOTIDE PROBE COMPRISING SAID POLYNUCLEOTIDE AND METHODS USING SAID PROBE
ORAL PHARMACEUTICAL COMPOSITION OF A COMPOUND HAVING ANTIFUNGAL ACTIVITY AND A METHOD FOR ITS PREPARATION
DS-CDMA SPREAD SPECTRUM COMMUNICATION SYSTEM WITH REDUCED PEAK-TO-AVERAGE POWER RATIO (PAPR)
PROCESS FOR THE PREPARATION OF 5-BROMO-2-FLUOROBENZENEBORONIC ACID
TRANSDERMAL DELIVERY SYSTEM
DENATURANT STABLE AND/OR PROTEASE RESISTANT, CHAPERONE-LIKE OLIGOMERIC PROTEINS, POLYNUCLEOTIDES ENCODING SAME AND THEIR USES
BIOSENSOR DEVICE AND METHOD FOR DETECTING A BINDING EVENT BETWEEN A LIGAND AND LIGAND-BINDING AGENT
HORMONE REPLACEMENT THERAPY
INDOLOPYRROLOCARBAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
